Eli Lilly (LLY) Cash from Investing Activities Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
-16.79% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-250.17% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
21.90% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-586.62% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-60.18% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
526.51% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-76.02% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
73.75% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-16.79% |
| Dec 31, 2025 |
-45.87% |
| Sep 30, 2025 |
25.52% |
| Jun 30, 2025 |
16.58% |
| Mar 31, 2025 |
-184.73% |
| Dec 31, 2024 |
34.32% |
| Sep 30, 2024 |
-30.00% |
| Jun 30, 2024 |
-378.92% |
| Mar 31, 2024 |
-70.96% |
| Dec 31, 2023 |
-209.97% |
| Sep 30, 2023 |
-222.46% |
| Jun 30, 2023 |
44.45% |
| Mar 31, 2023 |
33.62% |
| Dec 31, 2022 |
-94.86% |
| Sep 30, 2022 |
-54.96% |
| Jun 30, 2022 |
-71.01% |
| Mar 31, 2022 |
19.16% |
| Dec 31, 2021 |
28.17% |
| Sep 30, 2021 |
-96.65% |
| Jun 30, 2021 |
-129.71% |
| Mar 31, 2021 |
-20.98% |
| Dec 31, 2020 |
-1,528.26% |
| Sep 30, 2020 |
26.03% |
| Jun 30, 2020 |
-444.92% |
| Mar 31, 2020 |
86.18% |
| Dec 31, 2019 |
93.72% |
| Sep 30, 2019 |
-6.46% |
| Jun 30, 2019 |
-98.05% |
| Mar 31, 2019 |
-4,408.93% |
| Dec 31, 2018 |
-139.87% |
| Sep 30, 2018 |
77.35% |
| Jun 30, 2018 |
239.33% |
| Mar 31, 2018 |
88.09% |
| Dec 31, 2017 |
240.30% |
| Sep 30, 2017 |
-121.22% |
| Jun 30, 2017 |
-120.29% |
| Mar 31, 2017 |
-883.22% |
| Dec 31, 2016 |
-564.37% |
| Sep 30, 2016 |
-39.40% |
| Jun 30, 2016 |
-659.70% |
| Mar 31, 2016 |
-190.42% |
| Dec 31, 2015 |
111.64% |
| Sep 30, 2015 |
65.44% |
| Jun 30, 2015 |
138.90% |
| Mar 31, 2015 |
-58.60% |
| Dec 31, 2014 |
-76.80% |
| Sep 30, 2014 |
-74.79% |
| Jun 30, 2014 |
62.54% |
| Mar 31, 2014 |
-71.34% |
| Dec 31, 2013 |
25.87% |
| Sep 30, 2013 |
-611.23% |
| Jun 30, 2013 |
-224.86% |
| Mar 31, 2013 |
307.74% |
| Dec 31, 2012 |
11.42% |
| Sep 30, 2012 |
86.84% |
| Jun 30, 2012 |
79.71% |
| Mar 31, 2012 |
-1,502.70% |
| Dec 31, 2011 |
-19.96% |
| Sep 30, 2011 |
-27.88% |
| Jun 30, 2011 |
-151.74% |
| Mar 31, 2011 |
22.62% |
| Dec 31, 2010 |
-515.22% |
| Sep 30, 2010 |
-1,264.70% |
| Jun 30, 2010 |
-838.69% |
| Mar 31, 2010 |
-123.14% |
